↓ Skip to main content

Elevated Plasma Moxifloxacin Concentrations and SLCO1B1 g.−11187G>A Polymorphism in Adults with Pulmonary Tuberculosis

Overview of attention for article published in Antimicrobial Agents and Chemotherapy, April 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news
1 news outlet
policy
2 policy sources
twitter
1 X user

Readers on

mendeley
46 Mendeley
Title
Elevated Plasma Moxifloxacin Concentrations and SLCO1B1 g.−11187G>A Polymorphism in Adults with Pulmonary Tuberculosis
Published in
Antimicrobial Agents and Chemotherapy, April 2018
DOI 10.1128/aac.01802-17
Pubmed ID
Authors

Marc Weiner, Jon Gelfond, Teresa L. Johnson-Pais, Melissa Engle, Charles A. Peloquin, John L. Johnson, Erin E. Sizemore, William R. Mac Kenzie

Abstract

Moxifloxacin exhibits concentration-dependent prolongation of human QTc intervals and bactericidal activity againstMycobacterium tuberculosisHowever, moxifloxacin plasma concentrations are variable between patients. We evaluated whether human gene polymorphisms affect moxifloxacin plasma concentrations in tuberculosis patients from two geographic regions. We enrolled a convenience sample of 49 adults with drug-sensitive pulmonary tuberculosis from Africa and the United State s enrolled in two treatment trials of moxifloxacin as part of multidrug therapy. Pharmacokinetic parameters were evaluated by noncompartmental techniques. Human single-nucleotide polymorphisms of transporter genes were evaluated with analysis of covariance on moxifloxacin exposure and peak concentration (Cmax). Moxifloxacin area under the concentration-time curve from 0 to 24 h (AUC0-24) and Cmaxwere significantly increased by drug mg/kg dosage and genotype of variant g.-11187G>A in theSLCO1B1gene (rs4149015), but not by geographic region. Median moxifloxacin AUC0-24was 46% higher and Cmax30% higher in 4 (8% of) participants who had theSLCO1B1g.-11187 AG genotype compared with 45 participants who had the wild type GG genotype (median from model, AUC0-2434.4 vs. 23.6 μg*h/mL,P=.005; Cmax3.5 vs. 2.7 μg/mL,P=.009, ANCOVA). Because moxifloxacin exhibits concentration-dependent prolongation of human QTc intervals, and prolonged QTc intervals are associated with cardiac arrhythmia, further study is needed to evaluate risk associated with theSLCO1B1g.-11187G>A variant.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 46 100%

Demographic breakdown

Readers by professional status Count As %
Other 8 17%
Student > Master 6 13%
Student > Bachelor 5 11%
Researcher 4 9%
Student > Doctoral Student 2 4%
Other 8 17%
Unknown 13 28%
Readers by discipline Count As %
Medicine and Dentistry 9 20%
Biochemistry, Genetics and Molecular Biology 8 17%
Pharmacology, Toxicology and Pharmaceutical Science 5 11%
Economics, Econometrics and Finance 2 4%
Agricultural and Biological Sciences 1 2%
Other 6 13%
Unknown 15 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 May 2022.
All research outputs
#2,360,991
of 26,017,215 outputs
Outputs from Antimicrobial Agents and Chemotherapy
#1,129
of 15,783 outputs
Outputs of similar age
#47,874
of 343,721 outputs
Outputs of similar age from Antimicrobial Agents and Chemotherapy
#42
of 233 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 15,783 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 343,721 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 233 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.